Does Medication related Osteonecrosis of the Jaw Affect Maxillary Sinus Volume and Mucosal Thickness?

Creative Commons License

YILMAZ ASAN C., GÖNEN Z. B., Akkoyun E. F., KILIÇ E., ALKAN A.

MEANDROS MEDICAL AND DENTAL JOURNAL, cilt.21, sa.1, ss.12-18, 2020 (ESCI, TRDizin) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 21 Sayı: 1
  • Basım Tarihi: 2020
  • Doi Numarası: 10.4274/meandros.galenos.2018.44366
  • Dergi Adı: MEANDROS MEDICAL AND DENTAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.12-18
  • Anahtar Kelimeler: Maxillary sinus, bisphosphonate osteonecrosis, BISPHOSPHONATE-RELATED OSTEONECROSIS, SURGEONS POSITION PAPER, ZOLEDRONIC-ACID, IN-VITRO, AMERICAN ASSOCIATION, RISK-FACTORS, CANCER, PAMIDRONATE, MANAGEMENT
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Bezmiâlem Vakıf Üniversitesi Adresli: Evet

Özet

Objective: Bisphosphonates (BPs) are commonly prescribed drugs because of their antiresorptive effects. However, BPs may cause medication-related osteonecrosis of the jaw (MRONJ). This study aimed to compare the maxillary sinus volumes and mucosal thickening of patients with MRONJ and healthy patients.